QPT — Quest PharmaTech Balance Sheet
0.000.00%
Last trade - 00:00- CA$3.38m
- CA$4.30m
Annual balance sheet for Quest PharmaTech, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | 2026 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS/A | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.264 | 0.375 | 0.717 | 0.205 | 0.014 |
| Net Total Receivables | 0 | 0.221 | 0.1 | 0 | — |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.288 | 0.622 | 0.836 | 0.225 | 0.033 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.016 | 0.003 | 0 | — | — |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 91 | 26.8 | 24.5 | 22.6 | 27.8 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Current Liabilities | 0.623 | 1.11 | 1.32 | 1.17 | 1.33 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.623 | 1.11 | 1.32 | 1.17 | 1.33 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 90.4 | 25.7 | 23.2 | 21.4 | 26.4 |
| Total Liabilities & Shareholders' Equity | 91 | 26.8 | 24.5 | 22.6 | 27.8 |
| Total Common Shares Outstanding |